1. Home
  2. VCYT vs SYNA Comparison

VCYT vs SYNA Comparison

Compare VCYT & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • SYNA
  • Stock Information
  • Founded
  • VCYT 2006
  • SYNA 1986
  • Country
  • VCYT United States
  • SYNA United States
  • Employees
  • VCYT N/A
  • SYNA N/A
  • Industry
  • VCYT Medical Specialities
  • SYNA Computer peripheral equipment
  • Sector
  • VCYT Health Care
  • SYNA Technology
  • Exchange
  • VCYT Nasdaq
  • SYNA Nasdaq
  • Market Cap
  • VCYT 2.6B
  • SYNA 2.7B
  • IPO Year
  • VCYT 2013
  • SYNA 2002
  • Fundamental
  • Price
  • VCYT $34.84
  • SYNA $65.64
  • Analyst Decision
  • VCYT Buy
  • SYNA Strong Buy
  • Analyst Count
  • VCYT 9
  • SYNA 7
  • Target Price
  • VCYT $39.89
  • SYNA $92.17
  • AVG Volume (30 Days)
  • VCYT 895.7K
  • SYNA 381.9K
  • Earning Date
  • VCYT 11-05-2025
  • SYNA 11-06-2025
  • Dividend Yield
  • VCYT N/A
  • SYNA N/A
  • EPS Growth
  • VCYT N/A
  • SYNA N/A
  • EPS
  • VCYT 0.34
  • SYNA N/A
  • Revenue
  • VCYT $479,129,000.00
  • SYNA $1,074,300,000.00
  • Revenue This Year
  • VCYT $14.48
  • SYNA $11.05
  • Revenue Next Year
  • VCYT $9.79
  • SYNA $9.89
  • P/E Ratio
  • VCYT $102.86
  • SYNA N/A
  • Revenue Growth
  • VCYT 19.91
  • SYNA 11.98
  • 52 Week Low
  • VCYT $22.61
  • SYNA $41.80
  • 52 Week High
  • VCYT $47.32
  • SYNA $89.81
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 59.94
  • SYNA 38.43
  • Support Level
  • VCYT $31.81
  • SYNA $66.44
  • Resistance Level
  • VCYT $36.85
  • SYNA $70.40
  • Average True Range (ATR)
  • VCYT 1.40
  • SYNA 1.95
  • MACD
  • VCYT 0.06
  • SYNA -0.56
  • Stochastic Oscillator
  • VCYT 60.91
  • SYNA 3.34

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.

Share on Social Networks: